TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1.7% | 20.1% | 18.3% | 38.9% | 23.0% | 69.0% | 9.9% | 200.9% | 5.5% | 4.0% | 1,008.2% | 177.4% | 418.5% | 227.2% | 332.4% | 415.8% | 369.0% | 347.9% | 474.1% | 395.6% | 331.5% | 208.9% | 176.2% | 135.1% | 79.2% | 104.8% | 139.9% | 68.6% | 8.5% | 47.3% | 61.8% | 69.8% | 54.9% | 50.4% | 74.4% | 40.0% | 40.6% | 3.3% | 8.1% | 7.0% | 12.0% | |
| 98.3% | 79.9% | 81.7% | 61.1% | 77.0% | 31.0% | 90.1% | -100.9% | 94.5% | 96.0% | -908.2% | -77.4% | -318.5% | 100.0% | 100.0% | 100.0% | 100.0% | -247.9% | -374.1% | -295.6% | -231.5% | -108.9% | -76.2% | -35.1% | 20.8% | -4.8% | -39.9% | 31.4% | 91.5% | 52.7% | 38.2% | 30.2% | 45.1% | 49.6% | 25.6% | 60.0% | 59.4% | 96.7% | 100.0% | 93.0% | 89.4% | |
| 167.5% | 738.1% | 1,314.1% | 1,223.3% | 920.3% | 1,130.7% | 574.2% | 207.1% | 410.4% | 332.1% | 1,008.2% | 177.4% | 418.5% | 227.2% | 332.4% | 415.8% | 369.0% | 370.8% | 484.1% | 405.4% | 356.5% | 221.7% | 187.9% | 149.0% | 92.6% | 118.1% | 156.7% | 82.7% | 50.2% | 51.2% | 61.8% | 69.8% | 54.9% | 50.0% | 74.4% | 40.0% | 40.6% | 15.2% | 32.9% | 22.7% | 24.6% | |
| 106.3% | 357.8% | 673.3% | 693.6% | 489.9% | 653.9% | 297.0% | 106.5% | 170.5% | 161.8% | 471.8% | 85.0% | 206.2% | 112.0% | 132.5% | 165.1% | 150.6% | 160.5% | 214.3% | 200.8% | 161.4% | 144.0% | 144.9% | 153.7% | 130.7% | 59.6% | 184.2% | 140.2% | 102.9% | 61.2% | 115.4% | 119.6% | 100.0% | 75.7% | 119.4% | 70.4% | 91.7% | 40.4% | 100.1% | 68.4% | 65.9% | |
| 273.9% | 1,095.9% | 1,987.4% | 1,917.0% | 1,410.2% | 1,784.6% | 871.1% | 313.6% | 581.0% | 493.9% | 1,480.0% | 262.4% | 624.7% | 339.2% | 464.9% | 580.9% | 519.6% | 160.5% | 214.3% | 200.8% | 174.9% | 266.9% | 205.9% | 174.0% | 134.8% | 114.2% | 199.3% | 148.7% | 147.3% | 88.2% | 115.4% | 140.3% | 109.3% | 98.7% | 119.4% | 70.4% | 91.7% | 58.4% | 133.1% | 96.0% | 84.9% | |
| -175.6% | -1,016.1% | -1,905.7% | -1,855.8% | -1,333.3% | -1,753.6% | -781.1% | -207.5% | -486.4% | -397.9% | -1,380.0% | -162.4% | -524.7% | -239.2% | -364.9% | -480.9% | -419.6% | -408.4% | -588.4% | -496.4% | -406.4% | -375.8% | -282.1% | -209.1% | -114.1% | -119.0% | -239.1% | -117.3% | -55.8% | -35.5% | -77.3% | -110.2% | -64.2% | -49.1% | -93.8% | -10.4% | -32.3% | 38.3% | -33.1% | -2.9% | 4.5% | |
| 1.8% | 16.3% | 69.2% | 60.9% | 50.0% | 47.3% | 25.7% | 9.1% | 16.6% | 25.9% | 147.2% | 30.2% | 64.9% | 27.2% | 50.1% | 75.9% | 63.4% | 62.4% | 84.9% | 89.9% | 16.2% | 78.0% | 16.2% | 19.3% | 12.4% | 3.8% | 5.3% | 4.1% | 3.9% | 3.5% | 4.3% | 4.5% | 3.7% | 3.4% | 4.2% | 2.5% | 2.9% | 1.3% | 0.0% | 0.0% | 1.1% | |
| -173.8% | -1,032.4% | -1,941.6% | -1,876.1% | -1,544.1% | -1,770.4% | -780.7% | -202.8% | -468.1% | -339.6% | -1,358.2% | -151.6% | -514.9% | -222.2% | -417.4% | -418.8% | -402.9% | -265.0% | -557.3% | -404.1% | -423.7% | -385.8% | -301.1% | -206.2% | -124.6% | -97.3% | -208.2% | -103.2% | -48.3% | -28.6% | -71.7% | -106.8% | -59.6% | -47.7% | -91.9% | 279.5% | -14.5% | 159.2% | -36.6% | -23.1% | 56.5% | |
| 4.3% | 150.5% | 174.4% | 12.9% | 20.3% | 154.8% | 1.7% | -28.9% | -5.1% | -20.7% | 1.5% | 0.8% | -44.7% | 0.2% | 0.7% | 0.3% | 0.5% | 47.0% | 1.6% | 1.7% | 0.1% | 1.0% | 4.0% | 0.0% | 4.1% | 0.0% | 3.8% | 10.6% | 8.7% | 19.9% | 8.7% | 9.2% | 15.7% | 35.1% | -3.6% | 70.1% | -32.5% | 26.2% | -8.7% | 5.3% | 4.9% | |
| -178.0% | -1,182.9% | -2,115.9% | -1,889.1% | -1,564.4% | -1,925.2% | -782.4% | -173.9% | -462.9% | -318.9% | -1,359.7% | -152.3% | -470.2% | -222.4% | -418.2% | -419.0% | -403.4% | -312.0% | -558.9% | -405.8% | -267.6% | -214.3% | -196.6% | -74.1% | 7,361.9% | -70.7% | -212.0% | -113.8% | -57.0% | -48.4% | -80.4% | -115.9% | -75.3% | -82.8% | -88.2% | 209.3% | 18.1% | 133.0% | -27.9% | -28.5% | 51.6% | |
| -169.6% | -1,008.5% | -1,837.3% | -1,787.4% | -1,471.9% | -1,700.5% | -744.2% | -190.3% | -446.6% | -308.3% | -1,179.6% | -115.6% | -434.5% | -191.2% | -355.6% | -327.8% | -328.6% | -401.2% | -577.6% | -303.3% | -380.8% | -251.2% | -204.0% | -173.4% | -103.6% | -91.4% | -216.8% | -99.8% | -35.9% | -35.3% | -64.4% | -86.5% | -52.4% | -40.5% | -85.0% | 283.6% | -9.5% | 163.8% | -31.8% | 4.0% | 65.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.